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There was a labeling error in Fig. 1 F. The left panel of F should say PB T cells instead of Jurkat. The corrected figure appears below.
Figure 1. Accumulation of T-bet–expressing T lympho-
cytes in the LP of patients with Crohn’s disease. (A and B)
Analysis of T-bet expression in the LP from patients with
IBD and control patients. Colon cryosections were stained
with a T-bet antibody and sections were analyzed by immu-
nofluorescense microscopy and confocal laser microscopy,
respectively. Many T-bet positive cells were seen in patients
with Crohn’s disease but not ulcerative colitis. Data are rep-
resentative of four to five patients per group. (C) Immuno-
histochemical double staining analysis of the cellular expres-
sion of T-bet plus CD3 in consecutive cross sections.
Cryosections from patients with Crohn’s disease (n   10), ul-
cerative colitis (n   4) and control patients (n   8) were
stained with antibodies to CD3 and T-bet, as indicated. One
representative experiment is shown. Double positive cells
are indicated by arrows. (D) Quantitative analysis of T-bet-
positive CD3  LP T cells in patients with Crohn’s disease,
ulcerative colitis, and control patients. The percentage of
double-positive T cells in four to six patients per group was
quantified as specified in Materials and Methods. Data repre-
sents mean values   SD. (E) Analysis of T-bet expression by
LPMCs from patients with Crohn’s disease and control pa-
tients. Nuclei were counterstained with DAPI, as specified in
Materials and Methods. Most T cells from control patients
showed weak expression of T-bet in perinuclear areas,
whereas high cytoplasmic and nuclear expression was noted
in patients with Crohn’s disease. (F) Double staining analysis
for GATA-3 and CD3 in the LP of patients with Crohn’s
disease (CD) and control patients (con), as indicated. Colon
cryosection were stained with a polyclonal anti–GATA-3 an-
tibody and anti-CD3 antibodies. There was a marked reduc-
tion of GATA-3 expression in LP T cells from patients with
Crohn’s disease compared with control patients. Data are
representative of four to six patients per group. Cytospins
from PMA-plus ionomycin-stimulated Jurkat cells served as a
positive control.